Spinal-Cord MRI in Multiple Sclerosis: Conventional and Nonconventional MR Techniques

Neuroimaging Clinics of North America

Volumn 19, Issue 1, 2009, Pages 81-99

  Bot, Joseph CJ ^a   Barkhof, Frederik ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atrophy; Demyelination; DWI; Functional MRI; Magnetic resonance imaging; Multiple sclerosis; Spectroscopy; Spinal cord

Indexed keywords

BRAIN; CELL LOSS; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL EVALUATION; COMPARATIVE STUDY; DEMYELINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEASIBILITY STUDY; FOLLOW UP; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; MULTIPLE SCLEROSIS; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPINAL CORD; SPINAL CORD LESION; VALIDATION STUDY;

DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MULTIPLE SCLEROSIS; SPINAL CORD;

EID: 57049154914     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2008.09.005     Document Type: Review

References (134)

1. Thorpe J.W., Kidd D., Kendall B.E., et al. Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy adults. Neurology 43 (1993) 2625-2631
2. Solomon M.A. MRI in MS diagnosis. Neurology 37 (1987) 1566-1567
3. Fazekas F., Offenbacher H., Fuchs S., et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 38 (1988) 1822-1825
4. Paty D.W., Oger J.J., Kastrukoff L.F., et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38 (1988) 180-185
5. Barkhof F., Filippi M., Miller D.H., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (1997) 2059-2069
6. Lee K.H., Hashimoto S.A., Hooge J.P., et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 41 (1991) 657-660
7. Lycklama à Nijeholt G.J., Barkhof F., Scheltens P., et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am J Neuroradiol 18 (1997) 1041-1048
8. Provenzale J.M., Barboriak D.P., Gaensler E.H., et al. Lupus-related myelitis: serial MR findings. AJNR Am J Neuroradiol 15 (1994) 1911-1917
9. Salmaggi A., Lamperti E., Eoli M., et al. Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients. Clin Exp Rheumatol 12 (1994) 389-394 [published erratum appears in Clin Exp Rheumatol 1994 Nov-Dec;12(6):695]
10. Simeon-Aznar C.P., Tolosa-Vilella C., Cuenca-Luque R., et al. Transverse myelitis in systemic lupus erythematosus: two cases with magnetic resonance imaging. Br J Rheumatol 31 (1992) 555-558
11. Boumpas D.T., Patronas N.J., Dalakas M.C., et al. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 17 (1990) 89-92
12. Sobue G., Yasuda T., Kumazawa K., et al. MRI demonstrates dorsal column involvement of the spinal cord in Sjogren's syndrome-associated neuropathy. Neurology 45 (1995) 592-593
13. Nishiura I., Tochio H., and Koyama T. Cervical intramedullary sarcoidosis. Neurochirurgia (Stuttg) 35 (1992) 163-166
14. Junger S.S., Stern B.J., Levine S.R., et al. Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology 43 (1993) 333-337
15. Lexa F.J., and Grossman R.I. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol 15 (1994) 973-982
16. Nesbit G.M., Miller G.M., Baker Jr. H.L., et al. Spinal cord sarcoidosis: a new finding at MR imaging with Gd-DTPA enhancement. Radiology 173 (1989) 839-843
17. Rieger J., and Hosten N. Spinal cord sarcoidosis. Neuroradiology 36 (1994) 627-628
18. Simon J.H. The contribution of spinal cord MRI to the diagnosis and differential diagnosis of multiple sclerosis. J Neurol Sci 172 Suppl 1 (2000) S32-S35
19. Bronskill M.J., McVeigh E.R., Kucharczyk W., et al. Syrinx-like artifacts on MR images of the spinal cord. Radiology 166 (1988) 485-488
20. Curtin A.J., Chakeres D.W., Bulas R., et al. MR imaging artifacts of the axial internal anatomy of the cervical spinal cord. AJR Am J Roentgenol 152 (1989) 835-842
21. Czervionke L.F., Czervionke J.M., Daniels D.L., et al. Characteristic features of MR truncation artifacts. AJR Am J Roentgenol 151 (1988) 1219-1228
22. Hinks R.S., and Quencer R.M. Motion artifacts in brain and spine MR. Radiol Clin North Am 26 (1988) 737-753
23. Levy L.M., Di C.G., Brooks R.A., et al. Spinal cord artifacts from truncation errors during MR imaging. Radiology 166 (1988) 479-483
24. Roemer P.B., Edelstein W.A., Hayes C.E., et al. The NMR phased array. Magn Reson Med 16 (1990) 192-225
25. Mikulis D.J., Wood M.L., Zerdoner O.A., et al. Oscillatory motion of the normal cervical spinal cord. Radiology 192 (1994) 117-121
26. Hittmair K., Mallek R., Prayer D., et al. Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. AJNR Am J Neuroradiol 17 (1996) 1555-1565
27. Bianco F. Is fast spin-echo superior to gradient-echo imaging in detecting spinal cord lesions or not?. AJNR Am J Neuroradiol 17 (1996) 194 [letter]
28. Filippi M., Yousry T.A., Alkadhi H., et al. Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR. J Neurol Neurosurg Psychiatr 61 (1996) 632-635
29. Stevenson V.L., Gawne-Cain M.L., Barker G.J., et al. Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast FLAIR and fast spin echo. J Neurol 244 (1997) 119-124
30. Lycklama à Nijeholt G.J., Castelijns J.A., Weerts J., et al. Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imaging. Am J Neuroradiol 19 (1998) 355-360
31. Bot J.C., Barkhof F., Nijeholt G.J., et al. Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis. Eur Radiol 10 (2000) 753-758
32. Sze G., Merriam M., Oshio K., et al. Fast spin-echo imaging in the evaluation of intradural disease of the spine. AJNR Am J Neuroradiol 13 (1992) 1383-1392
33. Kidd D., Thorpe J.W., Thompson A.J., et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43 (1993) 2632-2637
34. Thorpe J.W., Kidd D., Moseley I.F., et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46 (1996) 373-378
35. Keiper M.D., Grossman R.I., Brunson J.C., et al. The low sensitivity of fluid-attenuated inversion-recovery MR in the detection of multiple sclerosis of the spinal cord. AJNR Am J Neuroradiol 18 (1997) 1035-1039
36. Dietemann J.L., Thibaut-Menard A., Warter J.M., et al. MRI in multiple sclerosis of the spinal cord: evaluation of fast short-tan inversion-recovery and spin-echo sequences. Neuroradiology 42 (2000) 810-813
37. Cohen-Gadol A.A., Zikel O.M., Miller G.M., et al. Spinal cord biopsy: a review of 38 cases. Neurosurgery 52 (2003) 806-815
38. Kidd D., Thorpe J.W., Kendall B.E., et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatr 60 (1996) 15-19
39. Bot J.C., Barkhof F., Polman C.H., et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62 (2004) 226-233
40. Fog T. Topographic distribution of plaques in the spinal cord in multiple sclerosis. Arch Neurol Psychaiatry 63 (1950) 382-414
41. Fog T. The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand, Suppl 15 (1965) 1-161
42. Nijeholt G.J., Bergers E., Kamphorst W., et al. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 124 (2001) 154-166
43. Bergers E., Bot J.C., De Groot C.J., et al. Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology 59 (2002) 1766-1771
44. Bot J.C., Blezer E.L., Kamphorst W., et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 233 (2004) 531-540
45. Filippi M., and Rocca M.A. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 252 Suppl 5 (2005) v16-v24
46. Stevenson V.L., Moseley I.F., Phatouros C.C., et al. Improved imaging of the spinal cord in multiple sclerosis using three-dimensional fast spin echo. Neuroradiology 40 (1998) 416-419
47. Kameyama T., Hashizume Y., and Sobue G. Morphologic features of the normal human cadaveric spinal cord. Spine 21 (1996) 1285-1290
48. Stevenson V.L., Leary S.M., Losseff N.A., et al. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 51 (1998) 234-238
49. Evangelou N., DeLuca G.C., Owens T., et al. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 128 (2005) 29-34
50. Maravilla K.R., Weinreb J.C., Suss R., et al. Magnetic resonance demonstration of multiple sclerosis plaques in the cervical cord. AJR Am J Roentgenol 144 (1985) 381-385
51. Edwards M.K., Farlow M.R., and Stevens J.C. Cranial MR in spinal cord MS: diagnosing patients with isolated spinal cord symptoms. AJNR Am J Neuroradiol 7 (1986) 1003-1005
52. Honig L., and Sheremata W. Magnetic resonance imaging of spinal cord lesions in multiple sclerosis. J Neurol Neurosurg Psychiatr 52 (1989) 459-466
53. Uldry P.A., Regli F., and Uske A. Magnetic resonance imaging in patients with multiple sclerosis and spinal cord involvement: 28 cases. J Neurol 240 (1993) 41-45
54. Papadopoulos A., Gatzonis S., Gouliamos A., et al. Correlation between spinal cord MRI and clinical features in patients with demyelinating disease. Neuroradiology 36 (1994) 130-133
55. Bot J.C., Barkhof F., Nijeholt G., et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223 (2002) 46-56
56. Tartaglino L.M., Friedman D.P., Flanders A.E., et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195 (1995) 725-732
57. Bergers E., Bot J.C., van d V., et al. Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology. Ann Neurol 51 (2002) 652-656
58. Thielen K.R., and Miller G.M. Multiple sclerosis of the spinal cord: magnetic resonance appearance. J Comput Assist Tomogr 20 (1996) 434-438
59. Lycklama à Nijeholt G.J., Vanwalderveen M.A., Castelijns J.A., et al. Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 121 (1998) 687-697
60. Brex P.A., Leary S.M., O'Riordan J.I., et al. Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Neurosurg Psychiatr 70 (2001) 544-547
61. O'Riordan J.I., Losseff N.A., Phatouros C., et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J Neurol Neurosurg Psychiatr 64 (1998) 353-357
62. Brex P.A., O'Riordan J.I., Miszkiel K.A., et al. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology 53 (1999) 1184-1190
63. Miller D.H., Barkhof F., and Nauta J.J. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116 (1993) 1077-1094
64. Brasch R.C., Weinmann H.J., and Wesbey G.E. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol 142 (1984) 625-630
65. Carr D.H., and Gadian D.G. Contrast agents in magnetic resonance imaging. Clin Radiol 36 (1985) 561-568
66. Larsson E.M., Holtas S., and Nilsson O. Gd-DTPA-enhanced MR of suspected spinal multiple sclerosis. AJNR Am J Neuroradiol 10 (1989) 1071-1076
67. Silver N.C., Good C.D., Sormani M.P., et al. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis. J Neurol 248 (2001) 215-224
68. Vaithianathar L., Tench C.R., Morgan P.S., et al. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis: a quantitative T1 relaxation time mapping approach. J Neurol 250 (2003) 307-315
69. Barkhof F., and van Walderveen M. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond, B, Biol Sci 354 (1999) 1675-1686
70. Bachmann R., Reilmann R., Schwindt W., et al. FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla. Eur Radiol 16 (2006) 915-921
71. van Waesberghe J.H., Kamphorst W., De Groot C.J., et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46 (1999) 747-754
72. Turano G., Jones S.J., Miller D.H., et al. Correlation of SEP abnormalities with brain and cervical cord MRI in multiple sclerosis. Brain 114 (1991) 663-681
73. Wiebe S., Lee D.H., Karlik S.J., et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 32 (1992) 643-650
74. Schneider U., Wullenweber M., Hrastnik K., et al. Nuclear magnetic resonance tomography in multiple sclerosis: comparison of spinal and cerebral findings. Nervenarzt 66 (1995) 129-132 [German]
75. Filippi M., Campi A., Colombo B., et al. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 243 (1996) 502-505
76. Losseff N.A., Webb S.L., O'Riordan J.I., et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119 (1996) 701-708
77. Lin X., Tench C.R., Evangelou N., et al. Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging 14 (2004) 20S-26S
78. Stevenson V.L., Miller D.H., Leary S.M., et al. One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatr 68 (2000) 713-718
79. Zivadinov R., and Bakshi R. Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. Front Biosci 9 (2004) 647-664
80. van Walderveen M.A., Barkhof F., Pouwels P.J., et al. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 46 (1999) 79-87
81. Stevenson V.L., Miller D.H., Rovaris M., et al. Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology 52 (1999) 839-845
82. Rovaris M., Viti B., Ciboddo G., et al. Cervical cord magnetic resonance imaging findings in systemic immune-mediated diseases. J Neurol Sci 176 (2000) 128-130
83. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
84. Jeffery D.R., Mandler R.N., and Davis L.E. Transverse myelitis: retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50 (1993) 532-535
85. de S.J., Stojkovic T., Breteau G., et al. Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 124 (2001) 1509-1521
86. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59 (2002) 499-505
87. Kesselring J., Miller D.H., Robb S.A., et al. Acute disseminated encephalomyelitis: MRI findings and the distinction from multiple sclerosis. Brain 113 (1990) 291-302
88. Miller D.H., Scaravilli F., Thomas D.C., et al. Acute disseminated encephalomyelitis presenting as a solitary brainstem mass. J Neurol Neurosurg Psychiatr 56 (1993) 920-922
89. Sebastián de l.C.F., La Banda B.F., and Romero G.J. [Acute nontraumatic myelopathies: a review of 36 cases]. Rev Clin Esp 195 (1995) 380-386 [Spanish]
90. Aldeeb S.M., Yaqub B.A., Bruyn G.W., et al. Acute transverse myelitis: a localized form of postinfectious encephalomyelitis. Brain 120 (1997) 1115-1122
91. Mok C.C., Lau C.S., Chan E.T., et al. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 25 (1998) 467-473
92. Campi A., Filippi M., Comi G., et al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. Ajnr: American Journal of Neuroradiology 16 (1995) 115-123
93. April R.S., and Vansonnenberg E. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: clinicopathologic report and review of the literature. Neurology 26 (1976) 1066-1070
94. Gil-Neciga E., Salinas E., and Arenas C. [Devic's optic neuromyelitis. Follow-up of the evolution of the medullary lesions using magnetic resonance]. Rev Neurol 25 (1997) 241-244 [Spanish]
95. Tartaglino L.M., Croul S.E., Flanders A.E., et al. Idiopathic acute transverse myelitis: MR imaging findings. Radiology 201 (1996) 661-669
96. Pradhan S., Gupta R.K., and Ghosh D. Parainfectious myelitis: three distinct clinico-imagiological patterns with prognostic implications. Acta Neurol Scand 95 (1997) 241-247
97. Barkhof F., Scheltens P., Valk J., et al. Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium-enhanced STIR imaging. Neuroradiology 33 (1991) 70-71
98. Kovacs B., Lafferty T.L., Brent L.H., et al. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59 (2000) 120-124
99. Takahashi T., Fujihara K., Nakashima I., et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130 (2007) 1235-1243
100. Lalive P.H., Menge T., Barman I., et al. Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology 67 (2006) 176-177
101. Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130 (2007) 1224-1234
102. Roemer S.F., Parisi J.E., Lennon V.A., et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130 (2007) 1194-1205
103. Wingerchuk D.M., Lennon V.A., Pittock S.J., et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
104. Dale R.C., de S.C., Chong W.K., et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123 Pt 12 (2000) 2407-2422
105. Rovaris M., Inglese M., Viti B., et al. The contribution of fast-FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseases. J Neurol 247 (2000) 29-33
106. Polman C.H., Reingold S.C., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58 (2005) 840-846
107. Traboulsee A.L., and Li D.K. The role of MRI in the diagnosis of multiple sclerosis. Adv Neurol 98 (2006) 125-146
108. Tintore M., Rovira A., Martinez M.J., et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 21 (2000) 702-706
109. Charil A., Yousry T.A., Rovaris M., et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol 5 (2006) 841-852
110. Barkhof F., van Waesberghe J.H., Filippi M., et al. T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment. Brain 124 (2001) 1396-1402
111. Mainero C., De S.N., Iannucci G., et al. Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology 56 (2001) 1331-1334
112. Filippi M. In-vivo tissue characterization of multiple sclerosis and other white matter diseases using magnetic resonance based techniques. J Neurol 248 (2001) 1019-1029
113. Filippi M., Bozzali M., Horsfield M.A., et al. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology 54 (2000) 207-213
114. Agosta F., Benedetti B., Rocca M.A., et al. Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI. Neurology 64 (2005) 631-635
115. Valsasina P., Rocca M.A., Agosta F., et al. Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients. Neuroimage 26 (2005) 822-828
116. Valsasina P., Agosta F., Benedetti B., et al. Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr 78 (2007) 480-484
117. Benedetti B., Valsasina P., Judica E., et al. Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI. Neurology 67 (2006) 161-163
118. Agosta F., Absinta M., Sormani M.P., et al. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain 130 (2007) 2211-2219
119. Bjartmar C., Kidd G., Mork S., et al. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48 (2000) 893-901
120. Kendi A.T., Tan F.U., Kendi M., et al. MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 46 (2004) 764-769
121. Marliani A.F., Clementi V., bini-Riccioli L., et al. Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 Tesla. Magn Reson Med 57 (2007) 160-163
122. Blamire A.M., Cader S., Lee M., et al. Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy. Magn Reson Med 58 (2007) 880-885
123. Cooke F.J., Blamire A.M., Manners D.N., et al. Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord. Magn Reson Med 51 (2004) 1122-1128
124. Ciccarelli O., Wheeler-Kingshott C.A., McLean M.A., et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 130 (2007) 2220-2231
125. Stroman P.W., Krause V., Malisza K.L., et al. Characterization of contrast changes in functional MRI of the human spinal cord at 1.5 T. Magn Reson Imaging 19 (2001) 833-838
126. Stroman P.W., and Ryner L.N. Functional MRI of motor and sensory activation in the human spinal cord. Magn Reson Imaging 19 (2001) 27-32
127. Stroman P.W., Tomanek B., Krause V., et al. Mapping of neuronal function in the healthy and injured human spinal cord with spinal fMRI. Neuroimage 17 (2002) 1854-1860
128. Stroman P.W., Krause V., Malisza K.L., et al. Extravascular proton-density changes as a non-BOLD component of contrast in fMRI of the human spinal cord. Magn Reson Med 48 (2002) 122-127
129. Stroman P.W., Krause V., Malisza K.L., et al. Functional magnetic resonance imaging of the human cervical spinal cord with stimulation of different sensory dermatomes. Magn Reson Imaging 20 (2002) 1-6
130. Stroman P.W. Magnetic resonance imaging of neuronal function in the spinal cord: spinal FMRI. Clin Med Res 3 (2005) 146-156
131. Stroman P.W., Kornelsen J., and Lawrence J. An improved method for spinal functional MRI with large volume coverage of the spinal cord. J Magn Reson Imaging 21 (2005) 520-526
132. Stroman P.W. Discrimination of errors from neuronal activity in functional MRI of the human spinal cord by means of general linear model analysis. Magn Reson Med 56 (2006) 452-456
133. Agosta F., Valsasina P., Caputo D., et al. Tactile-associated recruitment of the cervical cord is altered in patients with multiple sclerosis. Neuroimage 39 (2008) 1542-1548
134. Agosta F., Valsasina P., Rocca M.A., et al. Evidence for enhanced functional activity of cervical cord in relapsing multiple sclerosis. Magn Reson Med 59 (2008) 1035-1042